CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors

The Dualistic Model of Ovarian Carcinogenesis

(2016) Robert J. Kurman et al.   AMERICAN JOURNAL OF PATHOLOGY

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Assessing the genetic architecture of epithelial ovarian cancer histological subtypes

(2016) Gabriel Cuellar-Partida et al.   HUMAN GENETICS

Cisplatin induces stemness in ovarian cancer

(2016) Andrew Wiechert et al.   Oncotarget

The immunohistochemical analysis of membrane-bound CD55, CD59 and fluid-phase FH and FH-like complement inhibitors in cancers of ovary and corpus uteri origin

(2015) Lucyna Kapka-Skrzypczak et al.   Central European Journal of Immunology

Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer

(2015) Praveena S. Thiagarajan et al.   STEM CELLS

Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance

(2015) Anil Belur Nagaraj et al.   Oncotarget

Cobalt and Nickel Stabilize Stem Cell Transcription Factor OCT4 through Modulating Its Sumoylation and Ubiquitination

(2014) Yixin Yao et al.   PLoS One

Establishment of Human Patient-Derived Endometrial Cancer Xenografts in NOD scid Gamma Mice for the Study of Invasion and Metastasis

(2014) Kenji Unno et al.   PLoS One

Systems biology of cisplatin resistance: past, present and future

(2014) L Galluzzi et al.   Cell Death & Disease

High-Throughput Flow Cytometry Screening Reveals a Role for Junctional Adhesion Molecule A as a Cancer Stem Cell Maintenance Factor

(2014) Justin D. Lathia et al.   Cell Reports

The role of membrane rafts in Lck transport, regulation and signalling in T-cells

(2013) Leandro N. Ventimiglia et al.   BIOCHEMICAL JOURNAL

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

(2013) Tuan Zea Tan et al.   EMBO Molecular Medicine

Integrated genomic characterization of endometrial carcinoma

(2013) Gad Getz et al.   NATURE

The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy

(2012) L. C. Hanker et al.   ANNALS OF ONCOLOGY

Mesenchymal stem cells are injured by complement after their contact with serum

(2012) Y. Li et al.   BLOOD

Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients

(2012) Balázs Győrffy et al.   ENDOCRINE-RELATED CANCER

Ten-Year Relative Survival for Epithelial Ovarian Cancer

(2012) Lauren A. Baldwin et al.   OBSTETRICS AND GYNECOLOGY

Stem cells in endometrium and endometrial cancer: Accumulating evidence and unresolved questions

(2011) Satoru Kyo et al.   CANCER LETTERS

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

Integrin Alpha 6 Regulates Glioblastoma Stem Cells

(2010) Justin D. Lathia et al.   Cell Stem Cell

ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays

(2009) Yifang Hu et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Concomitant PI3K–AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis

(2009) Lluis Catasus et al.   MODERN PATHOLOGY

Lin28-mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cells

(2009) Caihong Qiu et al.   NUCLEIC ACIDS RESEARCH

Post-Translational Regulation of Oct4 Transcriptional Activity

(2009) Jonathan P. Saxe et al.   PLoS One

Ovarian Cancer Pathogenesis: A Model in Evolution

(2009) Alison M. Karst et al.   Journal of Oncology

Prognostic Significance of CD55 Expression in Breast Cancer

(2008) J.-i. Ikeda et al.   CLINICAL CANCER RESEARCH